Development of tuberculosis in immunocompromised patients with a positive tuberculosis-specific IGRA

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 4, 2012, Pages 492-495

  Lange, B ^a   Vavra, M ^a   Kern, W V ^a   Wagner, D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Interferon gamma release a ssay; Risk of progression; Tuberculosis

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; TUBERCULOSIS;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 84858641689     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0416     Document Type: Article

References (17)

1. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184.
2. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a meta-analysis. Chest 2010; 137: 952-968.
3. Sester M, Sotgiu G, Lange C, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011; 37: 100-111.
4. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Negative and positive predictive value of a wholeblood interferon-γ release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 2011; 183: 88-95.
5. Lienhardt C, Fielding K, Hane A A, et al. Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal. PLoS One 2010; 5: e10508.
6. Hill P C, Jackson-Sillah D J, Fox A, et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One 2008; 3: e1379.
7. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008; 177: 1164-1170. (Pubitemid 351717577)
8. Kik S V, Franken W P, Mensen M, et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010; 35: 1346-1353.
9. Harstad I, Winje B A, Heldal E, Oftung F, Jacobsen G W. Predictive values of QuantiFERON®-TB Gold testing in screening for tuberculosis disease in asylum seekers. Int J Tuberc Lung Dis 2010; 14: 1209-1211.
10. Mahomed H, Hawkridge T, Verver S, et al. The tuberculin skin test versus QuantiFERON®-TB Gold in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One 2011; 6: e17984.
11. Bakir M, Millington K A, Soysal A, et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med 2008; 149: 777-787.
12. Lange B, Vavra M, Kern W V, Wagner D. Indeterminate results of a tuberculosis-specific interferon-gamma release assay in immunocompromised patients. Eur Respir J 2010; 35: 1179-1182.
13. Aichelburg M C, Rieger A, Breitenecker F, et al. Detection and prediction of active tuberculosis disease by a whole-blood i nterferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009; 48: 954-962.
14. Leung C C, Yam W C, Yew W W, et al. T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med 2010; 182: 834-840.
15. del Corral H, Paris S C, Marin N D, et al. IFN-gamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS One 2009; 4: e8257.
16. Kaplan J E, Benson C, Holmes K H, Brooks J T, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58(RR-4): 1-207.
17. Rangaka M X, Wilkinson K A, Glynn J R, et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2011; Aug 14 [Epub ahead of print].